Current Portfolio
Xilis
Micro-organoid technology for precision cancer therapy and improved drug discovery.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP 6
- Entry
2021
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.